-РНК Mycobacterium tuberculosis как фактор модулирования врожденного иммунитета при инфекции

January 6, 2022 — December 31, 2024

Azhikina T.L. (PI), Aseev L.V., Bychenko O.S., Grigorov A.S., Skvortsova Y.V.

Laboratory of regulatory transcriptomics

Grant, RSF

List of publications

  1. Bychenko OS, Khrulev AA, Svetlova JI, Tsvetkov VB, Kamzeeva PN, Skvortsova YV, Tupertsev BS, Ivanov IA, Aseev LV, Khodarovich YM, Belyaev ES, Kozlovskaya LI, Zatsepin TS, Azhikina TL, Varizhuk AM, Aralov AV (2023). Red light-emitting short Mango-based system enables tracking a mycobacterial small noncoding RNA in infected macrophages. Nucleic Acids Res 51 (6), 2586–2601
  2. Salina EG (2023). Mycobacterium tuberculosis Infection: Control and Treatment. Microorganisms 11 (4),
  3. Salina EG, Azhikina TL, Kana B (2023). Editorial: Mycobacterial dormancy, culturability, and resuscitation: state-of-the-art, challenges, and future prospects. Front Cell Infect Microbiol 13, 1201012
  4. Martini BA, Grigorov AS, Skvortsova YV, Bychenko OS, Salina EG, Azhikina TL (2023). Small RNA MTS1338 Configures a Stress Resistance Signature in Mycobacterium tuberculosis. Int J Mol Sci 24 (9), 7928
  5. Skvortsova YV, Bychenko OS, Azhikina TL (2023). Role of RIG-I-Like Receptors in the Activation of Innate Immunity in Tuberculosis. Russ. J. Bioorganic Chem. 49 (4), 742–750